Search

everythinglearnresearchcommunity

for

Search:↓

Some treatments for folliculitis decalvans work well, with tetracyclines and a mix of rifampicin and clindamycin being most effective.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

Different types of hair loss in lupus need careful diagnosis for proper treatment.

Early detection and stopping the drug are key to managing DRESS, and careful monitoring is important due to possible severe reactions.

Pseudopelade of Brocq is a unique hair loss condition, but its cause and development are still not fully understood.

Lichen planopilaris mostly affects women with fair skin and can look different on each person, needing early treatment to prevent hair loss.

Early diagnosis and treatment are crucial for preventing permanent hair loss in various scalp conditions, and while new treatments are promising, more research is needed to evaluate their effectiveness.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Familial frontal fibrosing alopecia affects premenopausal women too, and early diagnosis is important, but no proven medication exists yet.

Pioglitazone usually doesn't effectively treat or cure lichen planopilaris.

Minoxidil helps treat eyebrow thinning, monilethrix, early hair loss, and shortens chemo-related hair loss.

Type I interferons play a key role in the development of various skin diseases.

Certain leukemia drugs can cause severe skin reactions that may require stopping treatment.

Black women's unique hair characteristics and styling practices can lead to specific scalp conditions, which require early diagnosis and appropriate treatment.

Patients with chronic skin conditions on systemic treatments did not have worse COVID-19 outcomes and could resume their treatments after recovery.

Trichoscopy is useful for diagnosing and monitoring systemic lupus erythematosus, with certain hair and scalp changes indicating more active disease.

Longer hair loss leads to more severe CCCA; early treatment and avoiding damaging hairstyles help regrowth.

Treatments for Frontal Fibrosing Alopecia have not been proven effective.

COVID-19 may cause early hair loss similar to classic temporary hair loss, with further research needed.

Platelet-Rich Plasma (PRP) may help improve hair density in primary cicatricial alopecias (PCAs) patients, but more trials are needed to confirm its benefits.

Chinese patients with primary cicatricial alopecia often have folliculitis decalvans, benefit from treatment, but may experience relapse, with dermoscopy being a useful diagnostic tool.

COVID-19 can cause skin issues like chilblains and rashes, which may help in early detection, especially in patients without other symptoms.

COVID-19 can cause various skin problems, including reactions to protective gear and medication, with different rates reported worldwide, and more research is needed to fully understand these skin issues.

Herbal alternatives like saw palmetto and green tea may offer safe, effective treatment for hormonal hair loss.

COVID-19 can cause various skin issues, including rashes and hair loss, which usually heal on their own and don't always indicate severe illness.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.

The conclusion is that primary scarring alopecia is a complex condition that requires early and accurate diagnosis for effective treatment.

Altered retinoid metabolism in cicatricial alopecia suggests a balanced vitamin A diet may prevent the condition.

Taking L-tryptophan supplements might cause a condition similar to scleroderma in some people, which can get better after stopping the supplement and starting corticosteroid therapy.

Some drugs can cause skin and hair color changes, often reversible when the drug is stopped.